Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-FR
Language French French
Date Updated 2017-09-29 2017-08-17
Drug Identification Number 02444763 02444763
Brand name OXALIPLATIN OXALIPLATIN
Common or Proper name Oxaliplatin Oxaliplatin
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients OXALIPLATIN OXALIPLATIN
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1x20mL 1x20mL
ATC code L01XA L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-09-30 2017-08-18
Actual start date
Estimated end date 2017-10-31 2017-10-31
Actual end date 2017-09-20
Shortage status Avoided shortage Anticipated shortage
Company comments Other format available: OXALIPLATIN 5mg/mL 1x10mL OGVL Other format available: OXALIPLATIN 5mg/mL 1x10mL OGVL
Health Canada comments